biologic

(redirected from biologic response modifiers)
Also found in: Dictionary, Thesaurus.

biological

 [bi″o-loj´ĭ-k'l]
1. pertaining to biology.
2. a medicinal preparation made from living organisms and their products, such as a serum or vaccine.
biological clock the physiologic mechanism that governs the rhythmic occurrence of certain biochemical, physiologic, and behavioral phenomena in living organisms. See also biological rhythms.

bi·o·log·ic

, biological (bī'ō-loj'ik, -loj'i-kăl),
Relating to biology.

biologic

(bī′ə-lŏj′ĭk)
n.
A preparation that is synthesized from living organisms or their products, especially a human or animal protein, such as a hormone or antitoxin, that is used as a diagnostic, preventive, or therapeutic agent. Also called biological drug.
adj.
Variant of biological.

biologic

adjective Referring to biology; biological.
 
noun Any therapeutic serum, toxin, anti-toxin or analogous microbial product applicable to the prevention, treatment or cure of diseases or injuries; a bioengineered therapeutic agent—e.g., a hormone, antibody, cytokine—produced in bacteria, animals and other organisms.

bi·o·log·ic

, biological (bī'ŏ-loj'ik, -i-kăl)
Relating to biology.

bi·o·log·ic

, biological (bī'ŏ-loj'ik, -i-kăl)
Relating to biology.

biologic,

adj pertaining to biology.
biologic death,
n the permanent cessation of electrical activity in the central nervous system. Also called brain death.
biologic factors,
n the variables that influence life and living tissues.
biologic (permucosal) seal,
n the health-protecting zone between the living soft tissue and the post or implant in patients with full replacement dental work. Works to prevent bacteria and any other health-threatening organisms from breaching healthy tissue.
biologic science,
n the science that deals with life processes.
biologic value (BV),
n a number reached by comparing the amount of nitrogen retained with the amount absorbed to aid in determining protein quality.
biologic vector,
n the live carrier, usually an arthropod, in which an infectious organism matures prior to infecting a receiver.

biologic


biologic response modifiers
therapeutic agents used to increase or optimize immune responses. Includes immunomodulators, immunoaugmentators, immunoadjuvants, immunostimulators and immunopotentiators.
References in periodicals archive ?
Biologic response modifiers are able to trigger the immune system to indirectly affect tumours by increasing cytokines such as interferons and interleukins.
Biologic response modifiers may cause flu like symptoms including fever, chills, nausea and appetite loss.
Patients in the Mid-Atlantic, south Atlantic, and east south central states also were significantly less likely to be treated with an adjuvant biologic response modifier (odds ratios 0.
In the past decade, six biologic response modifier (BRM) agents targeting four different biologic targets have been approved by the Food and Drug Administration for the treatment of RA.
Of the respondents, 300 were taking a biologic response modifier (BRM) and 200 were taking a disease-modifying antirheumatic drug (DMARD).
Biologic response modifiers such as Remicade(R) and Enbrel(R) have been developed to counteract the effects of TNF-a, and have been known to relieve pain and swelling and limit joint damage.
See FDA briefing document on biologic response modifiers at http://www.
The first in a new class of rheumatoid arthritis drugs known as biologic response modifiers, ENBREL is an entirely novel approach to the management of rheumatoid arthritis.
Weiner is the Eastern Cooperative Oncology Group's (ECOG) Principal Investigator for the Fox Chase Cancer Center, the Chairman of the ECOG Committee on Biologic Response Modifiers, and is on the editorial boards for the Journal of Clinical Oncology and for Clinical Cancer Research.
ENBREL is the first in a class of rheumatoid arthritis drugs known as biologic response modifiers (BRMs), a new approach to RA management and the first breakthrough treatment in many years for people with rheumatoid arthritis.
17, 1992, the Biologic Response Modifiers Advisory Committee recommended that the drug be approved for metastatic renal cell carcinoma with labeling that alerts physicians to the toxic effects associated with its administration.
November 1998 - ENBREL becomes the first biologic response modifier to